Paydirt
TK
Insider

Tomer Kariv

Director

Tomer Kariv (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in KROS. The largest single filing was $85.0M of KROS (4,787,331 sh across 4 lots, as filed), executed Oct 15 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$85.0M
shares × price, as filed
Last traded
Oct 15 2025
Filed Oct 17 2025
Open performance→
Volume by month
$85.0M$42.5M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2025 · sells $85.0M
Buys $0 Sells $85.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names
KROS KROS KROS · 0 buys · 1 sell 1 filing
Recent filings
KROSSALE Keros Therapeutics, Inc. View filing → $85.0M
4,787,331 sh across 4 lots
Exec Oct 15 2025
Filed Oct 17 2025 · 5:30 PM ET